Růžička E - Search Results

1

Correction to: Pupillometry as an indicator of L-DOPA dosages in Parkinson's disease patients.

Bartošová O, Bonnet C, Ulmanová O, Šíma M, Perlík F, Růžička E, Slanař O. Bartošová O, et al. Among authors: ruzicka e. J Neural Transm (Vienna). 2018 Sep;125(9):1401. doi: 10.1007/s00702-018-1884-2. J Neural Transm (Vienna). 2018. PMID: 29644396

2

Amantadine infusion in treatment of motor fluctuations and dyskinesias in Parkinson's disease.

Růzicka E, Streitová H, Jech R, Kanovský P, Roth J, Rektorová I, Mecír P, Hortová H, Bares M, Hejduková B, Rektor I. Růzicka E, et al. J Neural Transm (Vienna). 2000;107(11):1297-306. doi: 10.1007/s007020070019. J Neural Transm (Vienna). 2000. PMID: 11145005 Clinical Trial.

3

[Organ changes induced by ergot derivative dopamine agonist drugs: time to change treatment guidelines in Parkinson's disease?].

Roth J, Ulmanová O, Růzicka E. Roth J, et al. Among authors: ruzicka e. Cas Lek Cesk. 2005;144(2):123-6. Cas Lek Cesk. 2005. PMID: 15807300 Czech.

4

Caudate nucleus atrophy in Huntington's disease and its relationship with clinical and genetic parameters.

Roth J, Klempìi J, Jech R, Zidovská J, Uhrová T, Doubek P, Ulmanová O, Brozová H, Volfová M, Serranová T, Ruzicka E. Roth J, et al. Among authors: ruzicka e. Funct Neurol. 2005 Jul-Sep;20(3):127-30. Funct Neurol. 2005. PMID: 16324236 Clinical Trial.

5

Tremor magnitude: a single index to assess writing and drawing in essential tremor.

Ulmanová O, Homann CN, Ulman R, Jech R, Capek V, Klempír J, Růzicka E. Ulmanová O, et al. Among authors: ruzicka e. Parkinsonism Relat Disord. 2007 May;13(4):250-3. doi: 10.1016/j.parkreldis.2006.04.010. Epub 2006 Jun 21. Parkinsonism Relat Disord. 2007. PMID: 16793316

6

Low incidence of restrictive valvulopathy in patients with Parkinson's disease on moderate dose of pergolide.

Růzicka E, Línková H, Penicka M, Ulmanová O, Nováková L, Roth J. Růzicka E, et al. J Neurol. 2007 Nov;254(11):1575-8. doi: 10.1007/s00415-007-0592-x. Epub 2007 Aug 24. J Neurol. 2007. PMID: 17712588 Clinical Trial.

7

No association with the ETM2 locus in Czech patients with familial essential tremor.

Zahorakova D, Ulmanova O, Kemlink D, Kofrankova M, Roth J, Martasek P, Ruzicka E. Zahorakova D, et al. Among authors: ruzicka e. Neuro Endocrinol Lett. 2010;31(4):549-52. Neuro Endocrinol Lett. 2010. PMID: 20802447

8

Validation of a new tool for automatic assessment of tremor frequency from video recordings.

Uhríková Z, Sprdlík O, Hoskovcová M, Komárek A, Ulmanová O, Hlaváč V, Nugent CD, Růžička E. Uhríková Z, et al. Among authors: ruzicka e. J Neurosci Methods. 2011 May 15;198(1):110-3. doi: 10.1016/j.jneumeth.2011.02.033. Epub 2011 Mar 29. J Neurosci Methods. 2011. PMID: 21396403

9

Does WOQ-9 help to recognize symptoms of non-motor wearing-off in Parkinson's disease?

Bareš M, Rektorová I, Jech R, Farníková K, Roth J, Růžička E, Kaňovský P, Rektor I, Pavlík T, Uhlířová L, Vydlák J. Bareš M, et al. Among authors: ruzicka e. J Neural Transm (Vienna). 2012 Mar;119(3):373-80. doi: 10.1007/s00702-011-0683-9. Epub 2011 Jul 17. J Neural Transm (Vienna). 2012. PMID: 21769622

10

Biomarkers demonstrate increased consumption, but not abuse, of ethanol in essential tremor.

Ulmanová O, Vinopalová M, Zima T, Růžička E. Ulmanová O, et al. Among authors: ruzicka e. J Neurol. 2012 Jun;259(6):1177-80. doi: 10.1007/s00415-011-6323-3. Epub 2011 Dec 7. J Neurol. 2012. PMID: 22146903

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

306 results

Search Page

Filters